GR3015913T3 - Recombinant alveolar surfactant protein. - Google Patents

Recombinant alveolar surfactant protein.

Info

Publication number
GR3015913T3
GR3015913T3 GR950401034T GR950401034T GR3015913T3 GR 3015913 T3 GR3015913 T3 GR 3015913T3 GR 950401034 T GR950401034 T GR 950401034T GR 950401034 T GR950401034 T GR 950401034T GR 3015913 T3 GR3015913 T3 GR 3015913T3
Authority
GR
Greece
Prior art keywords
proteins
alveolar surfactant
surfactant protein
disclosed
recombinant
Prior art date
Application number
GR950401034T
Other languages
English (en)
Inventor
James W Schilling
Robert T White
Barbara Cordell
Bradley J Benson
Original Assignee
Scios Nova Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Nova Inc filed Critical Scios Nova Inc
Publication of GR3015913T3 publication Critical patent/GR3015913T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
GR950401034T 1986-04-30 1995-04-25 Recombinant alveolar surfactant protein. GR3015913T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/857,715 US4933280A (en) 1984-12-11 1986-04-30 Recombinant DNA sequence encoding Alveolar Surfactant Protein

Publications (1)

Publication Number Publication Date
GR3015913T3 true GR3015913T3 (en) 1995-07-31

Family

ID=25326586

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950401034T GR3015913T3 (en) 1986-04-30 1995-04-25 Recombinant alveolar surfactant protein.

Country Status (14)

Country Link
US (1) US4933280A (el)
EP (1) EP0251449B1 (el)
JP (3) JPH0813839B2 (el)
KR (1) KR880701246A (el)
AT (1) ATE118035T1 (el)
AU (1) AU591566B2 (el)
CA (1) CA1340611C (el)
DE (1) DE3751033T2 (el)
DK (1) DK173173B1 (el)
ES (1) ES2072850T3 (el)
GR (1) GR3015913T3 (el)
HK (1) HK1005887A1 (el)
IL (1) IL82364A (el)
WO (1) WO1987006588A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761394A (en) * 1969-12-31 1973-09-25 Texaco Inc Catalytic cracking of naphtha
US5840527A (en) * 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
WO1987002037A1 (en) * 1985-09-26 1987-04-09 Genetics Institute, Inc. Pulmonary surfactant proteins
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト,ジエフリー エイ. 肺胞疎水性界面活性物質関連タンパク質
US6613734B2 (en) 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
AU4216689A (en) * 1988-08-11 1990-03-05 California Biotechnology, Inc. Method for stabilizing heterologous protein expression and vectors for use therein
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
EP0458167B1 (en) * 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6031075A (en) * 1996-02-05 2000-02-29 Children's Hospital Medical Center Mature alveolar SP-B and a process for producing the same
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.
WO2006013183A1 (en) 2004-08-06 2006-02-09 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
US9289388B2 (en) 2008-12-10 2016-03-22 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
JPS63503222A (ja) * 1986-05-06 1988-11-24 サイオス ノバ インコーポレイテッド 肺の疎水性界面活性物質に結合した分子量6,000ダルトンのタンパク質及びその多量体
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト,ジエフリー エイ. 肺胞疎水性界面活性物質関連タンパク質

Also Published As

Publication number Publication date
EP0251449A3 (en) 1989-04-19
CA1340611C (en) 1999-06-29
IL82364A (en) 1993-08-18
JPH08188598A (ja) 1996-07-23
DE3751033T2 (de) 1995-08-10
JPH09117290A (ja) 1997-05-06
US4933280A (en) 1990-06-12
JPH0813839B2 (ja) 1996-02-14
DK173173B1 (da) 2000-02-28
HK1005887A1 (en) 1999-01-29
IL82364A0 (en) 1987-10-30
DK151792A (da) 1992-12-17
ATE118035T1 (de) 1995-02-15
ES2072850T3 (es) 1995-08-01
JPH01500350A (ja) 1989-02-09
AU7480287A (en) 1987-11-24
EP0251449B1 (en) 1995-02-01
AU591566B2 (en) 1989-12-07
DE3751033D1 (de) 1995-03-16
EP0251449A2 (en) 1988-01-07
WO1987006588A1 (en) 1987-11-05
JP2766806B2 (ja) 1998-06-18
JP2584962B2 (ja) 1997-02-26
KR880701246A (ko) 1988-07-26

Similar Documents

Publication Publication Date Title
EP0210189A4 (en) RECOMBINANT ALVEOLAR SURFACE ACTIVE PROTEIN.
GR3015913T3 (en) Recombinant alveolar surfactant protein.
NZ223312A (en) Precursor protein of amyloid plaque protein and dna encoding it
ATE298800T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
EP0383837A4 (en) Alveolar surfactant proteins
EP0060491A3 (en) Protein pp16, process for concentrating and isolating it, and its use
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
EP0665888A4 (en) ALLERGEN FROM RAYGRASS POLLEN.
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
ATE356205T1 (de) Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen
DK694287A (da) Overfladeaktivt rekombinant-alveolaerprotein
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
MX9709846A (es) Secuencias de acidos nucleico y aminoacidos relacionados con el helicobacter pylori para procedimientos de diagnostico y terapeuticos.